Waage Christian's most recent trade in Gossamer Bio Inc was a trade of 440,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gossamer Bio Inc | Christian Waage | EVP, Tech Ops and Admin | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 440,000 | 440,000 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Christian Waage | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 35,900 | 35,900 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Christian Waage | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 17,950 | 84,130 (0%) | 0% | 0 | Common Stock | |
| Heron Therapeutics Inc | Christian Waage | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 35,900 | 35,900 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Christian Waage | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 17,950 | 84,130 (0%) | 0% | 0 | Common Stock | |
| Gossamer Bio Inc | Waage Christian | EVP, Tech Ops and Admin | Sale of securities on an exchange or to another person at price $ 1.16 per share. | 27 Mar 2024 | 6,430 | 585,934 (0%) | 0% | 1.2 | 7,430 | Common Stock |
| Heron Therapeutics Inc | Christian Waage | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 83,685 | 83,685 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Waage Christian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 13,948 | 66,180 (0%) | 0% | 0 | Common Stock | |
| Gossamer Bio Inc | Christian Waage | EVP, Tech Ops and Admin | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 375,000 | 375,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Christian Waage | EVP, Tech Ops and Admin | Grant, award, or other acquisition of securities at price $ 1.82 per share. | 24 Jul 2023 | 13,504 | 45,892 (0%) | 0% | 1.8 | 24,577 | Common Stock |
| Gossamer Bio Inc | Christian Waage | EVP, Tech Ops and Admin | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 3,376 | 3,376 | - | - | Common Stock Purchase Warrants | |
| Gossamer Bio Inc | Christian Waage | EVP, Tech Ops and Admin | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 190,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Christian Waage | EVP, Tech Ops and Admin | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 126,667 | 126,667 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Christian Waage | EVP, Tech Ops and Admin | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 105,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Christian Waage | EVP, Tech Ops and Admin | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 90,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Christian Waage | EVP, Tech Ops and Admin | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 71,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Christian Waage | EVP, Tech Ops and Admin | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Christian Waage | EVP, Tech Ops and Admin | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Christian Waage | EVP, Tech Ops and Admin | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 47,667 | 47,667 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Christian Waage | EVP, Tech Ops and Admin | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2023 | 157,500 | 157,500 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Christian Waage | EVP, Tech Ops and Admin | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 20 Mar 2023 | 18,500 | 32,388 (0%) | 0% | 1.2 | 22,145 | Common Stock |
| Heron Therapeutics Inc | Christian Waage | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 77,160 | 77,160 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Christian Waage | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 38,580 | 52,232 (0%) | 0% | 0 | Common Stock | |
| Gossamer Bio Inc | Christian Waage | EVP, Tech Ops and Admin | Purchase of securities on an exchange or from another person at price $ 7.21 per share. | 15 Jul 2022 | 6,934 | 13,888 (0%) | 0% | 7.2 | 49,994 | Common Stock |
| Gossamer Bio Inc | Christian Waage | EVP, Tech Ops and Admin | Sale of securities on an exchange or to another person at price $ 8.92 per share. | 23 Mar 2022 | 10,722 | 579,008 (0%) | 0% | 8.9 | 95,587 | Common Stock |
| Gossamer Bio Inc | Christian Waage | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 190,000 | 190,000 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Christian Waage | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2021 | 20,903 | 20,903 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Christian Waage | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2021 | 10,452 | 13,652 (0%) | 0% | 0 | Common Stock | |
| Heron Therapeutics Inc | Christian Waage | Director | Sale of securities on an exchange or to another person at price $ 9.73 per share. | 21 Dec 2021 | 300 | 3,200 (0%) | 0% | 9.7 | 2,920 | Common Stock |
| Heron Therapeutics Inc | Christian Waage | Director | Sale of securities on an exchange or to another person at price $ 12.31 per share. | 21 Sep 2021 | 300 | 3,500 (0%) | 0% | 12.3 | 3,692 | Common Stock |
| Heron Therapeutics Inc | Christian Waage | Director | Sale of securities on an exchange or to another person at price $ 15.20 per share. | 21 Jun 2021 | 300 | 3,800 (0%) | 0% | 15.2 | 4,559 | Common Stock |
| Gossamer Bio Inc | Christian Waage | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 9.48 per share. | 23 Mar 2021 | 5,490 | 588,199 (0%) | 0% | 9.5 | 52,051 | Common Stock |
| Gossamer Bio Inc | Christian Waage | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Christian Waage | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 45,000 | 593,689 (0%) | 0% | 0 | Common Stock | |
| Heron Therapeutics Inc | Christian Waage | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Christian Waage | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 3,000 | 4,400 (0%) | 0% | 0 | Common Stock | |
| Gossamer Bio Inc | Christian Waage | EVP & General Counsel | Purchase of securities on an exchange or from another person at price $ 9.53 per share. | 14 Oct 2020 | 2,500 | 6,954 (0%) | 0% | 9.5 | 23,818 | Common Stock |
| Heron Therapeutics Inc | Christian Waage | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2020 | 437 | 437 | - | - | Stock Option (Right to Buy) |